BioCryst Pharmaceuticals
BCRX
#4932
Rank
NZ$3.43 B
Marketcap
NZ$13.35
Share price
0.27%
Change (1 day)
8.19%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -NZ$0.62 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are NZ$0.96 Billion. In 2025 the company made an earning of NZ$0.48 Billion, an increase over its 2024 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.62 Billion-226.18%
2025 NZ$0.48 B-407.51%
2024 -NZ$0.16 Billion-61.56%
2023 -NZ$0.42 Billion-7.43%
2022 -NZ$0.45 Billion34.42%
2021 -NZ$0.34 Billion-0.55%
2020 -NZ$0.34 Billion67.88%
2019 -NZ$0.2 Billion7.55%
2018 -NZ$0.19 Billion53.92%
2017 -NZ$0.13 Billion19.29%
2016 -NZ$0.11 Billion28.19%
2015 -NZ$78.48 Million-4.8%
2014 -NZ$82.44 Million50.09%
2013 -NZ$54.93 Million-23.29%
2012 -NZ$71.61 Million-26.19%
2011 -NZ$97.01 Million54.78%
2010 -NZ$62.68 Million150.1%
2009 -NZ$25.07 Million-49.43%
2008 -NZ$49.56 Million14.07%
2007 -NZ$43.45 Million-49.31%
2006 -NZ$85.71 Million72.87%
2005 -NZ$49.58 Million22.08%
2004 -NZ$40.62 Million75.3%
2003 -NZ$23.17 Million-25.36%
2002 -NZ$31.05 Million225.05%
2001 -NZ$9.55 Million-56.6%
2000 -NZ$22.01 Million50.63%
1999 -NZ$14.61 Million38.05%
1998 -NZ$10.59 Million-52.46%
1997 -NZ$22.26 Million58.44%
1996 -NZ$14.05 Million-14.44%
1995 -NZ$16.42 Million28.57%
1994 -NZ$12.78 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-NZ$4.63 Billion 614.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$13.05 B-2,116.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-NZ$0.24 Billion-63.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
NZ$55.96 M-108.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-NZ$0.41 Billion-37.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.6 Billion-8.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-NZ$15 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-NZ$40.61 Million-93.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.36 Billion-45.14%๐Ÿ‡บ๐Ÿ‡ธ USA